Is the new, still under patent, insulin that much better than what would be available to a generic manufacturer? If the previous generation would work for plent

Is the new, still under patent, insulin that much better than what would be available to a generic manufacturer? If the previous generation would work for plenty of patients that’s a huge market opportunity.